FhuD: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 13: | Line 13: | ||
==INTERESTING FACTS== | ==INTERESTING FACTS== | ||
Unlike other periplasmic ligand binding protein (PLBP), FhuD does not have the characteristic fold of a bilobate domain connected by flexible β-strands at the base of the ligand binding pocket.<ref name="lu"/> This results in FhuD adopting a novel PLBP structure.<ref name="lu"/> As designated by its structure, FhuD binds hydroxamate siderophores into a primarily hydrophobic pocket allowing the assumption that both binding and release do not cause large scale opening/closing.<ref name="la"/> However in the binding pocket, several major ligand binding side chains have been noted in various positions depending on the ligand bound.<ref name="lu"/>,<ref name="la"/> Due to the ability of siderophore binding uptake systems to allow such a diverse array of siderophore bound molecules, new bacterial growth inhibiting agents may be developed.<ref name="lu"/> These agents will be delivered into the bacteria as silent “Trojan Horses” by the bacteria’s own uptake system.<ref name="lu"/> | Unlike other periplasmic ligand binding protein (PLBP), FhuD does not have the characteristic fold of a bilobate domain connected by flexible β-strands at the base of the ligand binding pocket.<ref name="lu"/> This results in FhuD adopting a novel PLBP structure.<ref name="lu"/> As designated by its structure, FhuD binds hydroxamate siderophores into a primarily hydrophobic pocket allowing the assumption that both binding and release do not cause large scale opening/closing.<ref name="la"/> However in the binding pocket, several major ligand binding side chains have been noted in various positions depending on the ligand bound.<ref name="lu"/>,<ref name="la"/> Due to the ability of siderophore binding uptake systems to allow such a diverse array of siderophore bound molecules, new bacterial growth inhibiting agents may be developed.<ref name="lu"/> These agents will be delivered into the bacteria as silent “Trojan Horses” by the bacteria’s own uptake system.<ref name="lu"/> | ||
==3D structures of FhuD== | |||
[[3hxp]] – BsFhuD – ''Bacillus subtilis''<br /> | |||
[[3g9q]] – BsFhuD residues 45-315<br /> | |||
[[1esz]] – EcFhuD + coprogen – ''Escherichia coli''<br /> | |||
[[1k2v]] – EcFhuD + desferal<br / > | |||
[[1k7s]] – EcFhuD + albomycin-δ 2<br /> | |||
[[1efd]] – EcFhuD + gallichrome | |||
==REFERENCES== | ==REFERENCES== | ||